Biktarvy, formally known as bictegravir, includes a effective single-tablet regimen for controlling HIV infection. This medication integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the virus's ability to multiply within the body, remarkably decreasing the viral burden. For many